- BlackRock reduced voting-rights stake in ChemoMetec to 14.97%, crossing below the 15% Danish threshold.
Major shareholder BlackRock trimmed its direct voting stake in ChemoMetec below 15%, the Danish mandatory disclosure trigger, while adding a small financial-instrument position to keep the combined holding at 15.08%. The filing is a technical ownership adjustment, not a sale signal or a strategic shift by BlackRock.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.